New York, November 20, 2017 – Octane’s Cocoon automated bioreactor is this year’s recipient of the Silver prize in the Health category of the Spark Design Awards, an 11-year-old competition that recognizes modern designs which innovate, change the game and, in some way, help humanity or the environment.

Cocoon certainly ticks off all these boxes. This breakthrough bioreactor technology automates the manufacturing of patient-specific cell and tissue therapies, taking personalized regenerative medicine to the next level.

“We at Octane are so proud of Cocoon and we are grateful to the jurors at Spark for recognizing Cocoon’s ability to transform regenerative medicine,” says Octane CEO Tim Smith.

Cell therapy for personalized medicine has demonstrated great potential for fighting diseases such as cancer. But current manual processes for producing patient-specific cells are time-consuming, inefficient and potentially prone to contamination.

With Cocoon, these manual processes are automated and accelerated to produce breakthrough patient-specific treatments that are economical, safe and commercially scalable.

“Fundamentally, the Cocoon system optimizes the biology of growing healthy cells and tissues for re-implantation into the patient,” says Smith. “It truly is a game changer in regenerative medicine.”

For press inquiries please contact Renee Thibodeau.
‍renee.thibodeau@octaneco.com
613-634-6345 x200

The Spark mission is to promote better living through better design. Spark Awards are tri-annual affairs, with different design categories judged in June and November in San Francisco and December in Hong Kong. Both design professionals and students actively participate throughout the year. Learn more about the Spark organization and mission at the landing page at www.sparkawards.com

‍